Diverse Clinical Phenotypes of Neuronal Intranuclear Inclusion Disease in South Korea

韩国神经元核内包涵体病的多种临床表型

阅读:2

Abstract

BACKGROUND AND PURPOSE: Neuronal intranuclear inclusion disease (NIID) is a progressive neurodegenerative disease characterized by a wide range of clinical manifestations. GGC-repeat expansion in NOTCH2NLC was recently identified as the genetic cause of NIID. Here we report clinical, radiological, pathological, and genetic findings in NIID patients. METHODS: Twenty-five NIID patients from 22 unrelated families of Korean ancestry were reviewed from 9 referral centers in South Korea. We compared clinical features between sporadic and familial NIID patients. We classified NIID patients according to their prominent symptoms. The presence of GGC repeat expansion was analyzed in 19 patients. RESULTS: The 25 reviewed NIID patients comprised 12 (48.0%) sporadic and 13 (52.0%) familial cases, with the latter showing a significantly higher proportion of males (p=0.027). The patients were classified into three subtypes based on the prominent symptoms: NIID-Episodic (44.0%), NIID-EPS (extrapyramidal symptoms) (36.0%), and NIID-Dementia (20.0%). Most patients (92.0%) also exhibited other symptoms, including peripheral neuropathy (60.0%), bladder dysfunction (48.0%), or ophthalmic problems (56.0%). Hyperintensities along the corticomedullary junctions in diffusion-weighted imaging and extensive white-matter hyperintensities in fluid-attenuated inversion-recovery imaging were observed in 96.0% and 100% of the patients, respectively. GGC repeat expansion in NOTCH2NLC was identified in 6 sporadic and 10 familial cases. The number of GGC repeats was not correlated with the onset age or clinical symptoms. CONCLUSIONS: This study has highlighted the diverse phenotypes and genetic profiles of Korean NIID patients, and provided valuable insights into this rare disorder.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。